Representative image (Pixabay)
The Drug Controller General of India has approved the first fully indigenously developed conjugate vaccine for pneumonia.
The vaccine has been developed by the Serum Institute of India Pvt. Ltd, Pune.
The Serum Institute first obtained the DGCI approval to conduct Phase I, Phase II and Phase III clinical trials of Pneumococcal Polysaccharide Conjugate Vaccine in India.
It has also conducted clinical trials in Gambia.
Earlier the demand for such vaccine was substantially met by licensed importers since the manufacturers were all based outside India,” the statement added.
streptococcus pneumonia: This vaccine is used for active immunisation against invasive disease and pneumonia caused by “streptococcus pneumonia” in infants.
The vaccine is administered intramuscularly.
Source: The Hindu and PIB
